Back to results
US 2026/0248912 A1Published application
Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response
AssigneesBarinthus Biotherapeutics North America, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Servic
InventorsGeoffrey Martin Lynn, Andrew Scott Ishizuka
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to novel peptide-based vaccines, methods of manufacturing the novel peptide-based vaccines and uses thereof for delivering peptide antigens to induce an immune response, and in particular a T cell response to a subject.
Claims26
1-40. (canceled)
A peptide antigen conjugate comprising the formula B1-A-B2, wherein
- A is a peptide antigen;
- B1 comprises a dipeptide selected from Val-Cit, Val-Leu, Val-Arg, and Leu-Arg;
- and
- B2 comprises a tetrapeptide selected from Ser-Pro-Val-Cit and Gly-Pro-Gly-Cit.
1 more element
Dependencies are inferred from the claim text.